A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3

Novella-Navarro, M; Cabrera-Alarcon, JL; Diaz-Torne, C; Aramburu-Munoz, F; Janta, I; de la O, MCO; Prada-Ojeda, A; Sala-Icardo, L; Urruticoechea-Arana, A; Lefebvre, PGD; Calvo-Aranda, E

Calvo-Aranda, E (corresponding author), Hosp Univ Infanta Leonor, Rheumatol Dept, Ave Gran Via Este, Madrid 28031, Spain.; Calvo-Aranda, E (corresponding author), Spanish Soc Rheumatol GEACSER, Crystal Induced Arthrit Study Grp, Madrid, Spain.

RHEUMATOLOGY INTERNATIONAL, 2020; 40 (7): 1081

Abstract

The aim of this study was to assess changes in the estimated glomerular filtration rate (eGFR) in gouty patients with chronic kidney disease (CKD) usi......

Full Text Link